US2004006045A1PendingUtilityA1
Methods for the treatment or prophylaxis of disease by inhibition of ornithine decarboxylase
Priority: Aug 1, 2000Filed: Jul 7, 2003Published: Jan 8, 2004
Est. expiryAug 1, 2020(expired)· nominal 20-yr term from priority
Inventors:Rolland Hebert
A61Q 7/00A61K 8/44A61K 47/61A61Q 7/02
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods to prevent or treat conditions or diseases treatable by inhibition of ornithine decarboxylase are disclosed.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A method for the treatment of a disease or a condition which is treatable by inhibition of ornithine decarboxylase, which comprises administration of a therapeutically active or nithine decarboxylase-inhibiting amount of a salt of 2-difluoromethyl-2,5-diaminopentanoic acid with chitosan.
2 . A method for the prevention of a disease or a condition which is preventable by inhibition of omithine decarboxylase, which comprises administration of a therapeutically active omithine decarboxylase-inhibiting amount of a salt of 2-difluoromethyl-2,5-diaminopentanoic acid with chitosan.
3 . The method as defined by claim 1 , wherein a salt of 2-difluoromethyl-2,5-diaminopentanoic acid with chitosan is administered to treat a disease or condition selected from the group consisting of cancer, benign prostatic hypertrophy, protozoal in fections, actinic keratosis, and hirsutism.
4 . The method as defined by claim 2 , wherein a salt of 2-difluoromethyl-2,5-diaminopentanoic acid with chitosan is administered to prevent a condition or disease selected from the group consisting of cancer, benign prostatic hypertrophy, HIV, prozoal infections, actinic keratosis, and hirsutism.
5 . A method wherein a salt of 2-difluoromethyl-2,5-diaminopentanoic acid with chitosan is administered topically to prevent hair growth.Join the waitlist — get patent alerts
Track US2004006045A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.